![Having problems reading this email? View it in your browser >> 29 October 2021 | News from EACS 2021 Contents Abacavir still causing serious cardiovascular problems First efficacy results from England's PrEP IMPACT Trial More screening of domestic ... Having problems reading this email? View it in your browser >> 29 October 2021 | News from EACS 2021 Contents Abacavir still causing serious cardiovascular problems First efficacy results from England's PrEP IMPACT Trial More screening of domestic ...](http://www.aidsmap.com/sites/default/files/inline-images/resistance-bulletin.png)
Having problems reading this email? View it in your browser >> 29 October 2021 | News from EACS 2021 Contents Abacavir still causing serious cardiovascular problems First efficacy results from England's PrEP IMPACT Trial More screening of domestic ...
![Toxins | Free Full-Text | Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine | HTML Toxins | Free Full-Text | Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine | HTML](https://www.mdpi.com/toxins/toxins-14-00138/article_deploy/html/images/toxins-14-00138-g001.png)